Teva to buy Barr Pharma for more than $7b #list #of #pharma #companies

Posted On Jul 22 2017 by

#barr pharma #from the September 2008 issue Teva to buy Barr Pharma for more than $7b. Teva Pharmaceutical confirmed its purchase of rival generic drugmaker Barr Pharmaceuticals for nearly $7.5 billion in a move that will boost Teva’s dominance as the world’s largest generic drugmaker. The deal continues consolidation of the generic-drug sector, driven by growth prospects as governments and other payers turn to the lower-priced medications and by the impending expiration of brand-name drug patents worth billions of dollars a year. Israel-based Teva Pharmaceutical Industries Ltd. said acquiring Montvale, N.J.-based Barr Pharmaceuticals Inc. the world’s No. 4 generic drug …


Teva Buys Drug Rival, Barr, for $ Billion #drug #chemistry

Posted On Jul 22 2017 by

#barr pharma # The New York Times Teva Buys Drug Rival, Barr, for $7.46 Billion July 19, 2008 Teva Pharmaceutical Industries said Friday that it would buy a rival generic drug maker, Barr Pharmaceuticals, for $7.46 billion to expand in both the United States and Europe. The deal is the latest in a wave of consolidation in the generic-drug sector that some analysts suspect will result in only a handful of major global players. Teva, the world’s largest generic drug company, plans to buy Barr for $66.50 a share in cash and stock. The price represents a 42 percent premium …


Sun Pharma to buy Dusa for $230 million #largest #pharmaceutical #companies

Posted On Jul 22 2017 by

#dusa pharma # Sun Pharma to buy Dusa for $230 million Updated: Thu, Nov 08 2012. 11 43 PM IST Mumbai: Sun Pharmaceuticals Industries Ltd. India s most valuable drug maker, has agreed to buy US-based skincare speciality company DUSA Pharmaceuticals Inc. for $230 million ( Rs. 1,251 crore). Under the terms of the agreement, a subsidiary of Sun Pharma will commence a tender offer for all outstanding common stock of DUSA at a price of $8 per share in cash, a 38% premium to the closing price on 7 November, the Indian company said on Thursday. The transaction has …


Tris Pharma Receives FDA Approval of Dyanavel™ XR (amphetamine) CII as Once-Daily Liquid for #acceleron

Posted On Jul 22 2017 by

#tris pharma # Tris Pharma Receives FDA Approval of Dyanavel™ XR (amphetamine) CII as Once-Daily Liquid for Treatment of ADHD in Children MONMOUTH JUNCTION, N.J. Oct. 20, 2015 /PRNewswire/ — Tris Pharma, Inc. (“Tris”) announced that the U.S. Food and Drug Administration (“FDA”) has approved Dyanavel XR (amphetamine), extended-release oral suspension, CII, for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children 6 years and older. With this approval, Dyanavel XR becomes the only once-daily, extended release amphetamine-based oral liquid approved for the treatment of ADHD in children. The approval is based on a Phase III randomized, placebo-controlled, laboratory classroom efficacy …


Job Listings – HudsonAlpha Institute for Biotechnology Jobs #jobs #pharmaceutical #industry

Posted On Jul 22 2017 by

#biotechnology jobs # View All Current Job Listings 9 Total Job(s). Located in Cummings Research Park in Huntsville, Alabama, one of the world’s leading science and technology business parks, the 153-acre HudsonAlpha Biotech Campus has state-of-the-art buildings and infrastructure for its unique blend of nonprofit research scientists, educators, and commercially-oriented entrepreneurs, who share work-space and know-how across organizational boundaries. Since opening its doors in 2008, the HudsonAlpha Biotech campus is home to more than 27 associate companies. Below is a list of the current openings located on the HudsonAlpha Biotech Campus. Click on filter to sort by company. Click on …


NCBiotech Jobs Network- 7 Tips for Crafting an Eye-Catching LinkedIn Profile #pharma #marketing #news

Posted On Jul 22 2017 by

#biotechnology jobs # NCBiotech Jobs Network- 7 Tips for Crafting an Eye-Catching LinkedIn Profile With more the 450 million users, LinkedIn is the networking tool for business professionals. Most employers and hiring managers rely on LinkedIn to recruit and vet talent. Moreover, LinkedIn profiles often populate the top responses of a Google search, making your profile a perfect opportunity to market your skills, abilities, and experiences. At this session, Heidi Scott Giusto will focus on teaching you 7 tips that will help you take your profile to the next level. Heidi Scott Giusto, Ph.D. owns Career Path Writing Solutions and …


Amgen to Buy Onyx for $10 #valeant #pharma

Posted On Jul 22 2017 by

#onyx pharma # Amgen to Buy Onyx for $10.4 Billion to Gain Cancer Drug Amgen Inc. agreed to buy Onyx Pharmaceuticals Inc. in a $10.4 billion transaction that gives Amgen access to a rapidly expanding cancer-drug market with a new product that offers sure revenue. Amgen will pay $125 a share for Onyx’s outstanding stock, the companies said in a statement yesterday. Net of estimated Onyx cash, the deal is worth $9.7 billion. Onyx’s Kyprolis, approved last year for a rare blood cancer, may spur more than $3 billion in revenue by 2021, according to analyst estimates compiled by Bloomberg. …


Promius Pharma – Receives FDA Approval for Sernivo (betamethasone dipropionate) Spray, % #actavis #pharma

Posted On Jul 22 2017 by

#promius pharma # Promius Pharma™ Receives FDA Approval for Sernivo (betamethasone dipropionate) Spray, 0.05% February 07, 2016 11:52 PM Eastern Standard Time HYDERABAD, India & PRINCETON, N.J.–( BUSINESS WIRE )–Dr. Reddy’s announced today that its US subsidiary, Promius Pharma TM. LLC, U.S. (BSE: 500124, NSE: DRREDDY, NYSE: RDY), has received approval for Sernivo™ (betamethasone dipropionate) Spray, 0.05% from the U.S. Food and Drug Administration (FDA). Sernivo Spray, a prescription topical steroid, is indicated for the treatment of mild to moderate plaque psoriasis in patients 18 years of age or older. The commercial launch of the product is planned for the …


Pharmaceutical company promises 1, 500 new jobs for Georgia – CBS46 News #actavis #pharma #manufacturing

Posted On Jul 22 2017 by

#pharmaceutical company jobs # Pharmaceutical company promises 1,500 new jobs for Georgia It s lunchtime at the Blue Willow Inn and business is booming. It hasn t always been this good. The restaurant fell into bankruptcy three years ago. But better times soon could be ahead when a pharmaceutical company opens up a manufacturing plant a few miles away which could bring in more than 1,500 new workers. Billie Van Dyke, who owns Blue Willow, hopes she gets her slice of the economic pie when Baxter International moves in. “That means my business is going to increase also,” Van Dyke …


Euro Pharma – Representatives for Pharmaceutical Manufacturers – Pharmaceutical Technology #best #pharma #companies

Posted On Jul 21 2017 by

#euro pharma # Euro Pharma – Representatives for Pharmaceutical Manufacturers Euro Pharma was established in 2003 with an objective of representing leading manufacturers of bulk drug intermediate products and generic pharmaceutical medicine in India. BULK DRUG IMPORTERS, EXPORTERS AND MANUFACTURERS Euro Pharma represents a dynamic and fast growing group of companies, including importers, exporters and manufacturer representatives. Associates of the company develop and manufacture products in multi-location state-of-the-art facilities, using kilo-labs, pilot plants and full commercial production plants. We are a global marketing company supported by our associated company in India. They manufacture products as per the international quality standard …